Sunny
Sunny is an MD candidate at Harvard Medical School. Previously, she spent seven years researching neurodegenerative diseases. Notably, she was a part of a group studying cell replacement therapy for Parkinson’s disease which, in 2021, entered a Phase I clinical trial for patients with advanced Parkinson's disease
Emma
Emma earned her BA in English from Sarah Lawrence and her MFA in Fiction from the Iowa Writers' Workshop. She has worked as a writing teacher, editor, and agent, and is now a freelance editor based in California.
Elizabeth
Elizabeth is an MD/PhD student at NYU School of Medicine's Medical Scientist Training Program. She holds a BA in Biology with a minor in English from Hunter College.